Chotivanich K, Tripura R, Das D, Yi P, Day N, Pukrittayakamee S
Antimicrob Agents Chemother. 2014; 58(6):3157-61.
PMID: 24663013
PMC: 4068498.
DOI: 10.1128/AAC.01924-13.
Tyner S, Lon C, Se Y, Bethell D, Socheat D, Noedl H
Malar J. 2012; 11:198.
PMID: 22694953
PMC: 3403988.
DOI: 10.1186/1475-2875-11-198.
Akala H, Eyase F, Cheruiyot A, Omondi A, Ogutu B, Waters N
Am J Trop Med Hyg. 2011; 85(1):34-41.
PMID: 21734121
PMC: 3122340.
DOI: 10.4269/ajtmh.2011.10-0674.
Van Tyne D, Park D, Schaffner S, Neafsey D, Angelino E, Cortese J
PLoS Genet. 2011; 7(4):e1001383.
PMID: 21533027
PMC: 3080868.
DOI: 10.1371/journal.pgen.1001383.
Spalding M, Eyase F, Akala H, Bedno S, Prigge S, Coldren R
Malar J. 2010; 9:338.
PMID: 21106088
PMC: 3001743.
DOI: 10.1186/1475-2875-9-338.
Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum.
Monatrakul P, Mungthin M, Dondorp A, Krudsood S, Udomsangpetch R, Wilairatana P
Malar J. 2010; 9:326.
PMID: 21078202
PMC: 2993733.
DOI: 10.1186/1475-2875-9-326.
A comparative study of a flow-cytometry-based assessment of in vitro Plasmodium falciparum drug sensitivity.
Karl S, Wong R, Pierre T, Davis T
Malar J. 2009; 8:294.
PMID: 20003396
PMC: 2799432.
DOI: 10.1186/1475-2875-8-294.
Artemisinin resistance in Plasmodium falciparum malaria.
Dondorp A, Nosten F, Yi P, Das D, Phyo A, Tarning J
N Engl J Med. 2009; 361(5):455-67.
PMID: 19641202
PMC: 3495232.
DOI: 10.1056/NEJMoa0808859.
In vitro antimalarial drug susceptibility in Thai border areas from 1998-2003.
Chaijaroenkul W, Na Bangchang K, Mungthin M, Ward S
Malar J. 2005; 4:37.
PMID: 16060967
PMC: 1201168.
DOI: 10.1186/1475-2875-4-37.
Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing.
Noedl H, Bronnert J, Yingyuen K, Attlmayr B, Kollaritsch H, Fukuda M
Antimicrob Agents Chemother. 2005; 49(8):3575-7.
PMID: 16048989
PMC: 1196223.
DOI: 10.1128/AAC.49.8.3575-3577.2005.
Drug susceptibility and genetic evaluation of Plasmodium falciparum isolates obtained in four distinct geographical regions of Kenya.
Mbaisi A, Liyala P, Eyase F, Achilla R, Akala H, Wangui J
Antimicrob Agents Chemother. 2004; 48(9):3598-601.
PMID: 15328137
PMC: 514731.
DOI: 10.1128/AAC.48.9.3598-3601.2004.
Field evaluation of a novel colorimetric method--double-site enzyme-linked lactate dehydrogenase immunodetection assay--to determine drug susceptibilities of Plasmodium falciparum clinical isolates from northwestern Thailand.
Brockman A, Singlam S, Phiaphun L, Looareesuwan S, White N, Nosten F
Antimicrob Agents Chemother. 2004; 48(4):1426-9.
PMID: 15047560
PMC: 375318.
DOI: 10.1128/AAC.48.4.1426-1429.2004.
Plasmodium falciparum-based bioassay for measurement of artemisinin derivatives in plasma or serum.
Teja-Isavadharm P, Peggins J, Brewer T, White N, Webster H, Kyle D
Antimicrob Agents Chemother. 2004; 48(3):954-60.
PMID: 14982789
PMC: 353064.
DOI: 10.1128/AAC.48.3.954-960.2004.
Histidine-rich protein II: a novel approach to malaria drug sensitivity testing.
Noedl H, Wernsdorfer W, Miller R, Wongsrichanalai C
Antimicrob Agents Chemother. 2002; 46(6):1658-64.
PMID: 12019072
PMC: 127202.
DOI: 10.1128/AAC.46.6.1658-1664.2002.
Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine.
Brockman A, Price R, van Vugt M, Heppner D, Walsh D, Sookto P
Trans R Soc Trop Med Hyg. 2001; 94(5):537-44.
PMID: 11132385
PMC: 4340572.
DOI: 10.1016/s0035-9203(00)90080-4.
Mefloquine pharmacokinetic-pharmacodynamic models: implications for dosing and resistance.
Simpson J, Watkins E, Price R, Aarons L, Kyle D, White N
Antimicrob Agents Chemother. 2000; 44(12):3414-24.
PMID: 11083649
PMC: 90214.
DOI: 10.1128/AAC.44.12.3414-3424.2000.
The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand.
Price R, Cassar C, Brockman A, Duraisingh M, van Vugt M, White N
Antimicrob Agents Chemother. 1999; 43(12):2943-9.
PMID: 10582887
PMC: 89592.
DOI: 10.1128/AAC.43.12.2943.
Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria.
van Vugt M, Brockman A, Gemperli B, Luxemburger C, Gathmann I, Royce C
Antimicrob Agents Chemother. 1998; 42(1):135-9.
PMID: 9449273
PMC: 105468.
DOI: 10.1128/AAC.42.1.135.
Assessment of three in vitro tests and an in vivo test for chloroquine resistance in Plasmodium falciparum clinical isolates.
Bickii J, Basco L, Ringwald P
J Clin Microbiol. 1998; 36(1):243-7.
PMID: 9431956
PMC: 124843.
DOI: 10.1128/JCM.36.1.243-247.1998.
In vitro activities of the biguanide PS-15 and its metabolite, WR99210, against cycloguanil-resistant Plasmodium falciparum isolates from Thailand.
Edstein M, Bahr S, Kotecka B, Shanks G, Rieckmann K
Antimicrob Agents Chemother. 1997; 41(10):2300-1.
PMID: 9333069
PMC: 164114.
DOI: 10.1128/AAC.41.10.2300.